/
/
/

Amwill Health Care Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-20%15%12%
--54%6%
----26%
256%307%52%15%

Peer Comparison

Symbol
ADANIENT-A
AEGISLOG-A
CPPLUS-A
PREMIERENE-A
REDINGTON-A
HONASA-A
LLOYDSENT-A
CELLO-A
JSLL-A
BLACKROSE-T
AMWILL-M
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
3,031₹419654 Cr56.37-8.91105.06₹9339 Cr
1,350.75₹45862 Cr36.6513.841.65₹898 Cr
3,857.4₹45287 Cr94.8912.0745.29₹368 Cr
962.75₹44033 Cr26.4510.245.28₹1510 Cr
390.45₹30661 Cr18.036.2224.36₹1490 Cr
473.55₹15489 Cr62.242.778.99₹200 Cr
69.31₹10686 Cr95.160.380.91₹283 Cr
335₹7647 Cr24.443.3217.46₹332 Cr
512.35₹6437 Cr27.225.3123.32₹222 Cr
106.6₹564 Cr19.712.046.4₹22 Cr
43₹86 Cr7.535.98₹11 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
₹20 Cr₹20 Cr₹5 L₹3 L₹3 L₹3 L
₹61 Cr₹49 Cr₹17 Cr₹5 Cr₹1 Cr-₹1 Cr
₹61 Cr₹49 Cr₹17 Cr₹5 Cr₹1 Cr-₹1 Cr
₹81 Cr₹69 Cr₹17 Cr₹5 Cr₹1 Cr-₹1 Cr
-₹27 L-₹22 L-₹16 L-₹10 L-₹6 L-₹3 L
₹30 L₹28 L₹29 L₹27 L₹15 L₹9 L
₹3 L₹6 L₹12 L₹16 L₹8 L₹5 L
₹2 Cr₹1 Cr₹29 L₹5 Cr₹2 Cr₹5 Cr
₹2 Cr₹78 L₹1 Cr₹2 Cr₹2 Cr₹4 Cr
₹0₹0₹0₹4 L₹12 L₹12 L
₹1 Cr₹10 L₹4 L₹6,000₹3,000₹1,000
₹6 Cr₹2 Cr₹2 Cr₹8 Cr₹5 Cr₹9 Cr
₹86 Cr₹71 Cr₹19 Cr₹12 Cr₹7 Cr₹8 Cr
₹0₹0₹0₹4 L₹12 L₹12 L
₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹73 L₹80 L
₹2 Cr₹1 Cr₹73 L₹52 L₹29 L₹65,000
₹1 Cr₹1 Cr₹61 L₹52 L₹44 L₹80 L
₹0₹0₹35 L₹0₹0₹0
₹3 Cr₹0₹0₹0₹0₹0
₹3 Cr₹0₹0₹0₹0₹0
₹28 L₹79 L₹21 L₹39 L₹48 L₹23 L
₹10 Cr₹47 Cr₹0₹0₹0₹0
₹15 Cr₹49 Cr₹1 Cr₹91 L₹93 L₹1 Cr
₹83 L₹55 L₹49 L₹3 Cr₹2 Cr₹2 Cr
₹21 Cr₹17 Cr₹13 Cr₹1 Cr₹88 L₹4 Cr
₹47 Cr₹3 Cr₹3 Cr₹7 Cr₹2 Cr₹5 L
₹42 L₹15 L₹40 L₹6 L₹3,000₹0
₹2 Cr₹2 Cr₹34 L₹6 L₹26 L₹27 L
₹72 Cr₹22 Cr₹17 Cr₹11 Cr₹6 Cr₹7 Cr
₹66 Cr₹20 Cr₹16 Cr₹4 Cr₹64 L-₹2 Cr
₹86 Cr₹71 Cr₹19 Cr₹12 Cr₹7 Cr₹8 Cr
₹40₹35₹3,432₹1,534₹496-₹362
₹40₹35₹11₹5₹2-₹1

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
₹15 Cr₹12 Cr₹17 Cr₹4 Cr₹3 Cr-₹1 Cr
-₹2 Cr-₹12 L-₹5 L₹12 L₹41 L₹65,000
-₹2 Cr-₹5 Cr-₹16 Cr₹1 Cr₹30 L₹1 Cr
₹11 Cr₹7 Cr₹93 L₹6 Cr₹4 Cr₹28 L
₹8 Cr₹6 Cr-₹3 Cr₹5 Cr₹3 Cr₹7 L
₹6 Cr-₹46 Cr-₹1 Cr-₹1 Cr-₹6 L-₹80 L
-₹6 L₹41 Cr-₹2 L-₹9 L₹0₹8 L
₹14 Cr₹67 L-₹4 Cr₹3 Cr₹3 Cr-₹66 L
₹2 Cr₹1 Cr₹6 Cr₹2 Cr-₹55 L₹10 L
₹16 Cr₹2 Cr₹1 Cr₹6 Cr₹2 Cr-₹55 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit51.60
Low (₹)0.00
Lower Circuit34.40
Prev Close43.00
52W High (₹)62.99
Price43.00
52W Low (₹)28.91

Share Market Cap & Key Ratios Overview

M.Cap (₹)86.02 Cr
Div. Yield (%)1.16
PE Ratio7.53
Debt to Equity0.00
Price to Book0.72
Book Value40.28
EPS (TTM)5.71
Face Value10.00
ROE (%)15.25

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
AMWILL-MNSE
LTP
1W Low
1W High
Market cap (₹)
3031+95 (3.24%)
2917.70
3141.40
4,19,654Cr
1350.75+80.2 (6.31%)
1235
1384
45,862Cr
3857.4+151.5 (4.09%)
3663.70
3900
45,287Cr
962.75-35.25 (-3.53%)
950
1004.95
44,033Cr
390.45+19.05 (5.13%)
369.55
403.55
30,661Cr
473.55+2.8 (0.59%)
464.95
483.50
15,489Cr
69.31-4.89 (-6.59%)
67.60
74.97
10,686Cr
335-7.5 (-2.19%)
332
345
7,647Cr
512.35-4.35 (-0.84%)
498.95
535
6,437Cr
106.6-5.8 (-5.16%)
106.60
115.90
564Cr
43+0 (0.00%)
41.50
44.50
86Cr

Amwill Health Care Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Amwill Health Care Ltd Quaterly Results Key Takeaways